ARTICLE | Company News
Novacta, The Wellcome Trust infectious news
October 13, 2008 7:00 AM UTC
Novacta will receive the second tranche of a £3.5 million ($6.2 million) award from Wellcome Trust to develop a compound to treat Clostridium difficile infection. The payment was triggered by Novacta'...